The North American dental biomaterial market will undergo moderate growth through 2027, largely driven by the rising popularity of dental implant treatments, many cases of which involve the use of dental biomaterials. Companies in this space are also investing in innovative technologies to expand revenues and gain shares in this market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for dental biomaterials in North America across a 10-year period.
As the market matures, companies are increasingly focusing on innovative technologies to gain a competitive advantage.
What innovations are being developed in the dental biomaterial space?
Which companies are expected to enter the dental biomaterial market with new technologies going forward?
What are the potential benefits associated with these novel products, and how will it affect the positions of the companies in the market?
Strategic acquisitions, partnerships, and distribution deals help manufacturers expand their product portfolios and customer bases.
Which companies have recently engaged in M&A activity, and how have these deals benefited them?
Which competitors have engaged in distribution relationships, and how are distribution agreements affecting the market?
- Dental Biomaterials - Market Insights - North America
Author(s): Meenu Sankar, MS
Meenu Sankar is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde.
Follow Meenu on Twitter:@meenu_sankarDRG